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Abstract
Rothmund-Thomson syndrome (RTS)(OMIM 268400) is a rare autosomal recessive genodermatosis characterized by
poikiloderma, small stature, skeletal and dental abnormalities, cataract and an increased risk of cancer. It is caused
by mutations in RECQL4 at 8q24. Immune deficiency is not described as a classical feature of the disease. Here we
report the appearance of granulomatous skin lesions complicating primary Varicella Zoster Virus infection in a tod-
dler with Rothmund Thomson syndrome and immune deficiency. Although granulomatous disorders are some-
times seen after Herpes zoster, they are even more rare after Varicella primary infection. Granulomas have hitherto
not been described in Rothmund-Thomson syndrome. With this report we aim to stress the importance of screen-
ing for immune deficiency in patients with Rothmund-Thomson syndrome.
Background
Rothmund-Thomson syndrome ((RTS) OMIM 268400)
is a rare autosomal recessively inherited genodermatosis
with a heterogeneous clinical presentation. It is charac-
terized by a characteristic facial rash appearing in
infancy (poikiloderma), short stature, radial ray defects,
variable degrees of osteopenia, sparse scalp hair, eye-
lashes and eyebrows, dental abnormalities and cataract.
Moreover, RTS patients are at increased risk of cancer
(especially osteosarcoma and non melanoma skin can-
cer, but also leukemia and a range of other tumors).
The syndrome was originally described in 1868 by the
German ophthalmologist Rothmund in patients with
rapidly progressive juvenile cataract associated with skin
abnormalities [1]. In the first half of the 20
th century the
English dermatologist Thomson mentioned two patients
with cutaneous lesions that were similar to those
reported by Rothmund, but without any ocular lesions
[2]. In 1953 these two medical conditions were desig-
nated as the Rothmund-Thomson syndrome [3].
Following the association of RTS to mutations in
RECQL4 at 8q24, two clinical-molecular subsets of RTS
have been proposed [4,5]. Mutations in RECQL4 are
present in approximately one third of the clinically diag-
nosed RTS patients (RTS type II) and these patients
phenotype is characterised by poikiloderma, bone
defects and an incresased risk of osteosarcoma. In RTS
type I patients, no RECQL4 mutations are found and
poikiloderma, juvenile cataracts and ectodermal dyspla-
sia dominate the clinical presentation [4]. The human
RECQL4 gene consists of 21 exons spanning 6.5kb and
encodes for a 1208 aminoacids protein [6]. There is evi-
dence that RECQL4 plays multiple key roles in DNA
metabolism, as it is involved in single-stranded DNA
annealing activity, DNA replication, double strand break
repair, and repair of UV or ionizing radiation induced
DNA damage [7]. RTS and the function of RECQL4
have recently been excellently reviewed by Larizza et al
[8].
We present a patient with RTS and immune defi-
ciency who developed granulomatous skin lesions after
primary Varicella zoster virus (VZV) infection. To our
knowledge granulomatous skin lesions have not been
reported in RTS. Although granuloma formation has * Correspondence: Isabelle.Meyts@uzleuven.be
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VZV infection.
Case presentation
The propositus is the second child of non-consangui-
neous healthy parents of Kaukasian descent. She was
born term with weight, length and head circumference
below the third percentile. At the age of 6 months she
developed serpiginous erythematous lesions on the facial
skin (Figure 1A). At the age of 18 months, she was diag-
nosed with chickenpox. Four weeks after appearance of
the first VZV lesions, the spots changed into deeply red-
violet indurated and painful skin lesions on the cheeks,
the ears and arms (Figure 1B). Talc powder had not
been used topically. The course of the chicken pox
infection was otherwise uncomplicated. Furthermore,
there was a history of recurrent pyogenic upper and
lower respiratory tract infections with chronic purulent
rhinorrhea and chronic productive coughing.
Upon physical examination at the age of 2y, we saw a
girl with weight and stature < P3. Inspection of the skin
showed atrophic and hyperpigmented skin lesions,
mixed with café-au-lait lesions. Also, the girl had a
p o i n t e dn o s ea sw e l la sl o n g ,f i n ef i n g e r sw i t ha b e r r a n t ,
finger-like thumbs with diminished flexion. There was
clubbing on inspection and crackles on lung ausculta-
tion. Heart tones were normal as were peripheral arter-
ial pulsations. Inspection of ears, nose and throat
showed bilateral glue ears, purulent rhinitis. Inspection
of the oral cavity showed that the lateral incisors were
joined with the mandibular canine teeth. Clinical neuro-
logical examination showed no abnormalities. Ophthal-
mologic examination was normal. Full immunological
investigation at the age of 3y revealed normal CD4(+)
counts (1572/mcl (normal range 500-2400), low CD8(+)
(191/mcL (normal range 300-1600/mcL)) and CD16/56
(+) (12/mcL (90-900/mcl)) cells. Naive T cells (CD4(+)
CD45RA(+)CD27(-)) were 72% of total CD4(+) T cells
(normal range 65-95%). Lymphocyte proliferative
responses to Candida, Tetanus toxoid, VZV, PMA/iono-
mycin, PHA, ConA were all normal. Total CD19(+) cells
were normal (929/mcl (normal range 200-2150)) but
percentage of switched memory B cells was low (CD19
(+)CD27(+)IgM(-)IgD(-)) (1% (normal range for age 1.5-
4.1%). The values of CD8 cells, NK cells and class-
switched B cells remained low at ages 4.5 and 6y. Also,
IgG2 (0.47 g/L (normal range 0.63-3.6 g/L)) and IgM
(0.27 g/L (normal range 0.34-1.34 g/L) were low. Speci-
fic antibodies against Poliovirus, measles and Hepatitis B
virus were lacking despite adequate immunization. VZV
IgG was present. Iso-hemagglutinin titers were mea-
sured twice and were low, both at the age of 3 years (1/
4) as well as at the age of 6 years (1/1). Moreover anti-
pneumococcal antibody response was low. These find-
ings point to a defect in anti-polysaccharide antibody
responses. Computerized tomography of the lungs
revealed various sites of consolidation, developing
bronchiectasis and mosaic perfusion. Histological exami-
nation of an indurated skin lesion on the arm revealed
superficial and deep non-caseating granulomas (Figure
1C-E). Histochemical stains for fungi and mycobacteria
(Ziehl-Neelsen) were negative. Electron microscopy
examination was performed and showed no evidence of
foreign bodies or presence of micro-organisms as the
cause of granuloma formation. Immunohistochemistry
did not show evidence of immune complex- or comple-
ment-mediated pathology. VZV could not be detected in
Figure 1 Clinical and histological view of granulomatous
lesions. A. Typical poikiloderma lesions on the cheek and ear.
B. Deeply red-violet granulomatous skin lesions on arms. C. Low
power microscopy of the skin lesion reveals superficial and deep
inflammation without repercussion on the epidermis, and several
lightly stained granulomas, surrounded by inflammatory cells.
Haematoxylin and eosin stain, original magnification ×
10. D. High power of a granuloma reveals a mixture of
epithelioid macrophages, scattered lymphocytes and lack of
caseous necrosis; the granuloma is surrounded by a narrow rim of
mononuclear inflammatory cells. Haematoxylin and eosin
stain, original magnification × 25. E. Immunohistochemical
staining highlighted the granulomas, composed of CD68(+)
macrophages. Immunohistochemical staining for CD68, original
magnification × 10.
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cultures for bacteria, mycobacteria or fungi were nega-
tive. No 16sPCR, pan-mycobacterial or Mycobacterium
tubercolusis PCR was performed.
A presumptive diagnosis of Rothmund-Thomson syn-
drome was made and supported by the finding of a
delayed bone age (2 y 10 m 24 d versus civil age of 3 y
11 m 18d) and of metaphyseal translucencies in tibia
and ulna. Genetic analysis confirmed the diagnosis as
the girl was heterozygous for 2 mutations in the
RECQL4 gene (1048-1049delAG; 1391-1G > A).
The patient is now 6 years old and doing well under
prophylactic antibiotics (amoxicilline) and subcutaneous
immunoglobulin therapy, daily chest physiotherapy and
nose washes, the combination of which significantly
reduced the morbidity of recurrent respiratory infec-
t i o n s .S h ep i c k e du pw e i g h ta n di sn o wt h r i v i n ga tP 3 .
The granulomatous skin lesions gradually diminished
and disappeared completely over a time span of several
months.
Discussion
We describe a patient with Rothmund-Thomson syn-
drome and humoral immune deficiency with granuloma-
tous skin lesions after a VZV infection. Up till now,
granulomatous skin lesions have not been reported in
patients with RTS.
Granulomas are formed as a result of exaggerated cel-
lular immune response to one or more external or self-
antigens and a subsequent accumulation of activated
macrophages and CD4(+ T cells at an inflammatory site.
Several organs can be affected: mainly the lungs, but
also the skin, the liver, lymphoid tissue and the spleen.
Granulomas can be seen in the context of primary
immunodeficiency disorders. Up to 20% of patients with
common variable immunodeficiency (CVID) develop
cutaneous and systemic granulomatous inflammation
[9,10]. Cutaneous and systemic granulomas have also
been observed in patients with cartilage hair hypoplasia
(unpublished observation), ataxia-telangiectasia, etc.
Obviously, granulomatous inflammation is the hallmark
of chronic granulomatous disease. Our patient had an
increased frequency of respiratory infections associated
with immune deficiency defined by low IgG2 and a
diminished specific antibody response together with low
CD8(+)T cells and low NK CD16(+) CD56(+)cells.
Moreover she developed granulomatous skin lesions
after primary VZV infection. The temporal and spatial
association between the skin lesions and the VZV infec-
tion is not a proof of VZV as the cause of the granu-
loma formation. However, the appearance of
granulomas does point to the possibility of immune
deficiency or immune dysregulation. In CVID patients,
granulomas are believed to develop in response to
intracellular pathogens [11,12]. Also, there seems to be
an association with lymphopenia, an inverted CD4/CD8
ratio and decreased T-cell proliferation in response to
mitogens and antigens[10]. Wehr et al. found that in
CVID granulomatous inflammation is associated with
reduced numbers of memory B cells[13]. Our patient
presented with antibody deficiency and low CD8 counts
as well as a low percentage of switched memory B cells.
Originally, immunodeficiency was not believed to be a
characteristic feature of RTS. Recently, an increasing
number of reports on increased susceptibility to infec-
tions and immune deficiency in RTS are emerging.
Kubota reported an RTS patient with susceptibility to
sinopulmonary infections and IgG4 deficiency [14]. Ito
reported a 4-year-old Japanese boy with RTS presenting
with herpes encephalitis at 5 months of age. The serum
level of immunoglobulin G was low and the responsive-
ness of peripheral blood mononuclear cells to bacterial
superantigens was poor [15]. Broom described a patient
with molecularly confirmed RTS who at the age of 7
months was admitted with Pneumocystis jiroveci pneu-
monia. Immunophenotyping revealed a T
-B
+NK
- pheno-
type with agammaglobulinemia consistent with severe
combined immunodeficiency. The patient received an
umbilical cord blood transplant with complete immune
reconstitution [16]. In 2007 Reix et al described 2 pedia-
tric patients in whom localized bronchiectasis developed
[17]. Thus, certainly a subset of patients with RTS
seems to suffer from clinically relevant immune defi-
ciency. Due to the limited number of reports we can
only speculate on a genotype-phenotype correlation in
this syndrome with respect to the immune deficiency.
Most patients reported with significant immune defi-
ciency did have RECQL4 mutations. The pathophysiol-
ogy of immune deficiency in RTS with RECQL4
mutations can probably be seen in the context of the
multiple roles of RECQL4 in DNA metabolism, as sum-
marized above. Thus, RTS II shares similarities with
chromosomal breakage syndromes like ataxia telangiec-
tasia, nijmegen breakage syndrome in which immunode-
ficiency is often present, as well as an increased risk for
cancer. Moreover, RECQL4 is highly expressed in the
thymus and KO mice have smaller thymi, suggesting a
role for RECQL4 in T cell development [18]. The pre-
sence of immune deficiency or aberrant immunological
function is in agreement with the emergence of granulo-
mas in our patient. In patients recently affected by
Herpes zoster several cutaneous reactions have been
described with granuloma annulare and other granulo-
matous disorders being most common. Foreign body
granulomas secondary to the use of talc have been
described; this possibility was excluded in our patient
[19]. Most patients proved to be immunosuppressed for
various reasons (age, hematological malignancy, HIV,
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ciency [20,21]. VZV DNA is inconsistently demonstrated
in the lesions, whether or not they manifest early
(weeks) or late (months) after the Herpes zoster infection
[22]. Nikkels et al. suggest that VZV envelope glycopro-
teins may trigger granuloma formation [23].
The occurrence of a new skin disorder exactly at the
site of another one, already healed was recognized as a
distinct dermatologic phenomenon named “istotopic
response”. Two cases of isotopic response at the site of
VZV infection were described in the extended literature
review in this paper [24]. However, we are aware that
we have not rigorously excluded a potential atypical
mycobacterial infection.
Conclusion
Immune deficiency or immune dysregulation is an
increasingly reported characteristic of Rothmund-Thom-
son syndrome. A high index of suspicion of immune
deficiency is warranted in patients with RTS as appro-
priate therapeutic measures may have significant impact
on short- and long-term morbidity and mortality.
Immune deficiency and/or immune dysregulation pre-
dispose to aberrant responses to infection or noxious
stimuli in the form of granulomatous inflammation. To
the best of our knowledge, this is the first report of
granulomas in a patient with Rothmund-Thomson syn-
drome. The immunodeficiency in our patient may have
contributed to the development of granulomas. In our
opinion, screening for immune deficiency is warranted
in every patient with Rothmund-Thomson syndrome
and more so in the event of recurrent infections or if an
unusual course of a common infection is encountered.
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